Equities

Hygeia Healthcare Holdings Co Ltd

Hygeia Healthcare Holdings Co Ltd

Actions
Health CareHealth Care Providers
  • Price (HKD)16.40
  • Today's Change-1.42 / -7.97%
  • Shares traded10.91m
  • 1 Year change-66.43%
  • Beta1.3600
Data delayed at least 15 minutes, as of Nov 22 2024 08:08 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Hygeia Healthcare Holdings Co Ltd is a China-based investment holding company principally involved in oncology medical business. Through its subsidiaries, the Company mainly operates three segments. The Hospital Business segment provides outpatient and inpatient services for patients through its own hospitals. The Radiotherapy Business segment provides radiotherapy center consulting services, as well as the leasing, sales, disposal, and post-sales repair and maintenance services of radiotherapy equipment. The Hospital Management Service segment provides management related services to other hospitals. The Company conducts its businesses in the domestic market.

  • Revenue in HKD (TTM)5.05bn
  • Net income in HKD787.77m
  • Incorporated2018
  • Employees8.37k
  • Location
    Hygeia Healthcare Holdings Co LtdRoom 702-707, Enterprise SquareNo.228 Meiyuan Road, Jing'an DistrictSHANGHAI ChinaCHN
  • Websitehttp://www.hygeia-group.com.cn/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
C-Mer Medical Holdings Ltd1.90bn63.00m2.57bn2.19k40.531.388.221.360.05060.05061.521.490.69232.3037.42579,346.803.540.92374.371.1232.0629.955.111.441.8212.640.16745.3311.0934.98383.427.8128.01--
Yunkang Group Ltd853.53m-297.66m4.35bn1.46k--2.11--5.10-0.4945-0.49451.423.320.183830.130.482565,252.10-6.386.70-11.8211.1934.2742.42-34.7310.991.73-2.460.379519.89-76.278.38-127.10--33.22--
Adicon Holdings Ltd3.35bn241.33m4.65bn5.46k19.322.4210.331.390.33180.33184.612.650.662613.031.80586,531.905.22--8.80--40.93--7.87--1.916.110.4213---32.15---65.50------
China Resources Medical Holdings Com Ltd10.71bn315.76m5.03bn19.64k15.540.75914.790.46980.24980.24988.475.110.618825.756.16530,909.402.193.244.394.8018.5920.293.546.600.7904195.560.224627.9527.9237.46-3.07-9.7753.23-10.66
Gushengtang Holdings Ltd2.90bn286.08m8.55bn2.90k31.083.4520.022.941.141.1411.5610.240.825113.3516.831,091,647.008.15-4.879.96-9.9130.2837.099.88-6.672.43--0.1351--43.0126.1839.45--26.99--
Jinxin Fertility Group Ltd3.11bn333.90m8.62bn3.78k25.530.792313.052.770.1230.1231.153.960.192731.6722.00951,368.702.082.642.413.0141.1941.7610.8114.900.53199.420.197541.5217.9524.78184.6015.6552.59--
Genertec Universal Medical Group Co Ltd14.56bn2.22bn9.04bn21.52k4.320.44023.020.62081.111.117.1210.860.161222.130.458690,619.302.682.964.234.7133.7239.2316.6519.151.34--0.693330.5813.0626.017.028.37119.406.06
Concord Healthcare Group Co Ltd507.51m-387.45m10.77bn691.00--5.26--21.23-0.5409-0.54090.70852.860.084113.026.12692,377.20-7.38---9.97---13.68---87.66--0.4955-3.000.5713--14.08--31.09------
Hygeia Healthcare Holdings Co Ltd5.05bn787.77m11.15bn8.37k14.291.5810.472.211.251.257.9911.270.470718.085.89612,735.607.376.758.868.3431.3232.1515.6515.210.967620.200.29179.3227.5739.7043.24204.9926.48--
Ping An Healthcare and Technology Co Ltd4.88bn-22.91m16.16bn1.45k--1.12152.193.31-0.0214-0.02144.5112.850.276621.343.842,784,958.00-0.1787-5.23-0.2172-6.4432.2826.28-0.646-13.964.71--0.0044---24.686.9649.28---26.31--
Jiangxi Rimag Group Co Ltd873.16m5.66m17.10bn1.67k3,019.2410.4584.4219.590.01590.01592.454.60------867,948.50--------37.35---1.20--2.193.340.2167--18.42--12,101.92------
Data as of Nov 22 2024. Currency figures normalised to Hygeia Healthcare Holdings Co Ltd's reporting currency: Hong Kong Dollar HKD

Institutional shareholders

24.28%Per cent of shares held by top holders
HolderShares% Held
E Fund Management Co., Ltd.as of 11 Aug 202331.27m5.00%
FIL Investment Management (Singapore) Ltd.as of 04 Nov 202422.16m3.54%
Foresight Fund Management Co., Ltd.as of 30 Jun 202416.75m2.68%
Aegon-Industrial Fund Management Co., Ltd.as of 30 Jun 202414.52m2.32%
FIL Investment Management (Hong Kong) Ltd.as of 04 Nov 202414.04m2.24%
Bank of Communications Schroder Fund Management Co., Ltd.as of 30 Jun 202413.39m2.14%
The Vanguard Group, Inc.as of 06 Nov 202412.63m2.02%
Norges Bank Investment Managementas of 30 Jun 202411.35m1.82%
Allianz Global Investors Asia Pacific Ltd.as of 30 Sep 202410.15m1.62%
Dimensional Fund Advisors LPas of 07 Nov 20245.61m0.90%
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.